Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol

NCT04349410 is registered in ClinicalTrials.gov with The Camelot Foundation as lead sponsor.

NCT NCT04349410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04349410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol
Lead sponsor
The Camelot Foundation
Phase
Phase 2/3
Overall status
Completed
Start date
April 11, 2020
Completion date
September 14, 2020
Enrollment
1,800 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19 positive